Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab)

Artikelnummer: SYB-CHBA069
Artikelname: Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab)
Artikelnummer: SYB-CHBA069
Hersteller Artikelnummer: CHBA069
Alternativnummer: SYB-CHBA069-100UG, SYB-CHBA069-1MG
Hersteller: Sanyou Bio
Kategorie: Antikörper
Applikation: ELISA, FA, FACS, Kinetics
Lulizumab is a monovalent Anti-Human CD28 Domain Antibody Antagonist designed for the treatment of autoimmune diseases.
Konzentration: 1mg/ml
UniProt: P16410
Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Reinheit: >95%
Formulierung: Lyophilize
Target-Kategorie: CTLA-4 / CD152,PDCD1 / PD-1 / CD279